Case confirmation rates.

Table 1 describes the case confirmation rates, i.e. the number of laboratory confirmed BUD cases divided by the total number of patients with suspected BUD (suspected cases) of whom samples were subjected to a certain diagnostic test; diagnostic samples from 202 suspected BUD cases (suspected cases) from three study sites in Togo (CHR Tsévié, CHP Sotouboua, USP Agbetiko) were collected within three years (September 2007 through August 2010);aNon-ulcerative lesions: FNA (fine needle aspiration) samples, punch biopsy samples and surgical biopsy samples were analyzed; ulcerative lesions: swab samples, FNA (fine needle aspiration) samples, punch biopsy samples and surgical biopsy samples were analyzed;bTest: MIC, microscopic examination for the detection of acid fast bacilli; swab samples and FNA samples were analyzed;cTest: PCR, polymerase chain reaction, gel-based IS2404 PCR; swab samples, FNA samples, punch biopsy samples and surgical biopsy samples were analyzed;dNA, not available;